Dermal open flow microperfusion for PK-based clinical bioequivalence studies of topical drug products

Topically applied drug products have experienced an extraordinary price increase in the United States, mostly due to a lack of generic products. Generic drug development is hindered by high costs and risks associated with clinical endpoint studies required to show bioequivalence (BE) of prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Birngruber, Thomas, Tiffner, Katrin I., Mautner, Selma I., Sinner, Frank M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723326/
https://www.ncbi.nlm.nih.gov/pubmed/36483734
http://dx.doi.org/10.3389/fphar.2022.1061178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723326/
https://www.ncbi.nlm.nih.gov/pubmed/36483734
http://dx.doi.org/10.3389/fphar.2022.1061178

Ejemplares similares